NCT03945396

Brief Summary

This study evaluates the efficacy of a multidisciplinary intervention (diet, exercise, motivational support and homeopathy or placebo) for overweight and obesity in Mexican adolescents. Half of study participants will receive the multidisciplinary intervention plus Calcarea carbonica ostrearum, a homeopathic medicine, while the other half will receive the same multidisciplinary intervention plus placebo.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started May 2019

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 6, 2019

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 7, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 10, 2019

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

August 25, 2021

Status Verified

August 1, 2021

Enrollment Period

3.6 years

First QC Date

May 7, 2019

Last Update Submit

August 24, 2021

Conditions

Keywords

ObesityOverweightHomeopathyCalcarea carbonica ostrearumMexico

Outcome Measures

Primary Outcomes (2)

  • Change from baseline in mean total weight in kilograms (kg)

    Weight measured with the participants barefooted and lightly dressed, with a Tanita scale Fitscan BC-545 F segmental body composition monitor. The scale has an eight electrode body composition monitor that displays twenty readings; ten whole body and ten segmental (arms, legs and trunk area).

    At baseline and week 4, 8 and 12.

  • Change from baseline in percentage of body fat

    Body fat measured with Tanita scale Fitscan BC-545 F segmental body composition monitor. Values greater than 30% for females, and 25% for males, are considered high and of risk

    At baseline and week 4, 8 and 12.

Secondary Outcomes (6)

  • Change from baseline in mean total body mass index (BMI).

    At baseline and week 4, 8 and 12.

  • Change from baseline in mean total fat mass index

    At baseline and week 4, 8 and 12.

  • Change from baseline in mean total lean body mass (kg).

    At baseline and week 4, 8 and 12.

  • Change from baseline waist-hip ratio.

    At baseline and week 4, 8 and 12.

  • Change from baseline in mean total lean muscle mass (kg).

    At baseline and week 4, 8 and 12.

  • +1 more secondary outcomes

Other Outcomes (11)

  • Change from baseline in mean total fasting serum glucose (mg/dL)

    At baseline and week 12.

  • Change from baseline in mean total fasting serum triglycerides (mg/dL)

    At baseline and week 12.

  • Change from baseline in mean total cholesterol (mg/dL)

    At baseline and week 12.

  • +8 more other outcomes

Study Arms (2)

Multidisciplinary intervention + homeopathic medication

EXPERIMENTAL

Multidisciplinary intervention (diet, exercise program, motivational support) and Calcarea carbonica ostrearum 30c. A single dose of Calcarea carbonica ostrearum 30C dissolved in a 30 ml bottle of 30% alcohol-distilled water. Patients will receive 8 drops PO three times per day prior agitation.

Drug: Homeopathic MedicationOther: Multidisciplinary intervention (Exercise program, diet, motivational support)

Multidisciplinary intervention + homeopathic placebo

ACTIVE COMPARATOR

Multidisciplinary intervention (diet, exercise program, motivational support) and placebo. Placebo will be prepared with 30% alcohol-distilled water only, in the same 30 ml bottle. Patients will receive 8 drops PO three times per day prior agitation.

Other: Multidisciplinary intervention (Exercise program, diet, motivational support)Drug: Homeopathic placebo

Interventions

A homeopathic mineral medicine, form of impure calcium carbonate, CaCO3, which can be found in nature in different niches, from limestone to eggshells.

Also known as: Calcarea carbonica ostrearum
Multidisciplinary intervention + homeopathic medication

Exercise program: includes a five-times per week routine: warm-up during 10 to 15 minutes, then 40 minutes of aerobic exercise that will be increased progressively until reaching 60 minutes. Thereafter, muscular strength initiating 5%, and increasing until 10 to 15% of body weight. Then, 10 to 15 minutes of stretching. Finally, 5 min cool-down. Diet: Subjects will receive a balance diet calculated based on energetic needs according FAO: 15-20% of proteins, 50-60% of carbohydrate, 20-25% of fat per day. Motivational support: 50 min session where empathy and neutral understanding of the perspective and feelings of the adolescent, and his family, are fostered to motivate the change and to state realistic goals in reducing weight.

Also known as: Combined dietary-behavioral-physical activity intervention
Multidisciplinary intervention + homeopathic medicationMultidisciplinary intervention + homeopathic placebo

A 30 ml bottle of 30% alcohol-distilled water.

Also known as: Placebo
Multidisciplinary intervention + homeopathic placebo

Eligibility Criteria

Age12 Years - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • to 19 years old.
  • At least elementary school.
  • Overweight (BMI ≥ 85th but \<95th percentile based on the Centers for Disease Control and Prevention growth chart) or obese (BMI ≥95th percentile).
  • Fasting serum glucose \<126 mg/dl.
  • Glycosylated hemoglobin \<6.5%.
  • With symptoms that match with Calcarea carbonica ostrearum.
  • Willingness to participate, and verbal and written consent.

You may not qualify if:

  • Pregnancy or breastfeeding.
  • Cases already undergoing treatment (homeopathic, nutritional or structured physical activity) for obesity within last three months.
  • Currently use of metformin, orlistat, insulin, other antidiabetic medication, contraceptive pills, medications with effects on lipid metabolism \[thiazide and loop diuretics, β and α receptor blockers, antiepileptic drugs (carbamazepine, phenytoin, valproic acid, phenobarbital), antipsychotics (clozapine), protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir, saquinavir), tamoxifen, raloxifene, isotretinoin, acitretin, ciclosporin, azathioprine, sirolimus\].
  • Any condition that prevents physical exercise.
  • Diabetes, hypertension, thyroid diseases, Down syndrome, mental retardation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Juárez de México

Mexico City, 07760, Mexico

Location

Related Publications (1)

  • Macias-Cortes E, Arellano-Alvarez S, Vega-Monroy S, Vera-Perez V, Llanes-Gonzalez L, Sanchez-Navarrete P, Enciso-Gonzalez D. Efficacy of Homeopathy in Addition to a Multidisciplinary Intervention for Overweight or Obesity in Mexican Adolescents: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial. Homeopathy. 2020 May;109(2):87-96. doi: 10.1055/s-0039-1697927. Epub 2020 Jan 20.

MeSH Terms

Conditions

OverweightObesity

Interventions

Diet

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Masking Details
Double-blind
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A randomized, placebo-controlled, double-blind, parallel, superiority trial with 3 month study duration.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of homeopathy outpatient service

Study Record Dates

First Submitted

May 7, 2019

First Posted

May 10, 2019

Study Start

May 6, 2019

Primary Completion

November 30, 2022

Study Completion

December 30, 2022

Last Updated

August 25, 2021

Record last verified: 2021-08

Locations